IBDEI089 ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20126,2)
 ;;=^5003257
 ;;^UTILITY(U,$J,358.3,20127,0)
 ;;=F14.922^^67^858^24
 ;;^UTILITY(U,$J,358.3,20127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20127,1,3,0)
 ;;=3^Cocaine Intox w/ Percept Disturb w/o Use D/O
 ;;^UTILITY(U,$J,358.3,20127,1,4,0)
 ;;=4^F14.922
 ;;^UTILITY(U,$J,358.3,20127,2)
 ;;=^5003272
 ;;^UTILITY(U,$J,358.3,20128,0)
 ;;=F14.129^^67^858^25
 ;;^UTILITY(U,$J,358.3,20128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20128,1,3,0)
 ;;=3^Cocaine Intox w/o Percept Disturb w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,20128,1,4,0)
 ;;=4^F14.129
 ;;^UTILITY(U,$J,358.3,20128,2)
 ;;=^5003243
 ;;^UTILITY(U,$J,358.3,20129,0)
 ;;=F14.229^^67^858^26
 ;;^UTILITY(U,$J,358.3,20129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20129,1,3,0)
 ;;=3^Cocaine Intox w/o Percept Disturb w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,20129,1,4,0)
 ;;=4^F14.229
 ;;^UTILITY(U,$J,358.3,20129,2)
 ;;=^5003258
 ;;^UTILITY(U,$J,358.3,20130,0)
 ;;=F14.929^^67^858^27
 ;;^UTILITY(U,$J,358.3,20130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20130,1,3,0)
 ;;=3^Cocaine Intox w/o Percept Disturb w/o Use D/O
 ;;^UTILITY(U,$J,358.3,20130,1,4,0)
 ;;=4^F14.929
 ;;^UTILITY(U,$J,358.3,20130,2)
 ;;=^5003273
 ;;^UTILITY(U,$J,358.3,20131,0)
 ;;=F14.121^^67^858^19
 ;;^UTILITY(U,$J,358.3,20131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20131,1,3,0)
 ;;=3^Cocaine Intox Delirium w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,20131,1,4,0)
 ;;=4^F14.121
 ;;^UTILITY(U,$J,358.3,20131,2)
 ;;=^5003241
 ;;^UTILITY(U,$J,358.3,20132,0)
 ;;=F14.221^^67^858^20
 ;;^UTILITY(U,$J,358.3,20132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20132,1,3,0)
 ;;=3^Cocaine Intox Delirium w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,20132,1,4,0)
 ;;=4^F14.221
 ;;^UTILITY(U,$J,358.3,20132,2)
 ;;=^5003256
 ;;^UTILITY(U,$J,358.3,20133,0)
 ;;=F14.921^^67^858^21
 ;;^UTILITY(U,$J,358.3,20133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20133,1,3,0)
 ;;=3^Cocaine Intox Delirium w/o Use D/O
 ;;^UTILITY(U,$J,358.3,20133,1,4,0)
 ;;=4^F14.921
 ;;^UTILITY(U,$J,358.3,20133,2)
 ;;=^5003271
 ;;^UTILITY(U,$J,358.3,20134,0)
 ;;=F14.10^^67^858^30
 ;;^UTILITY(U,$J,358.3,20134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20134,1,3,0)
 ;;=3^Cocaine Use DO,Mild,Uncomp
 ;;^UTILITY(U,$J,358.3,20134,1,4,0)
 ;;=4^F14.10
 ;;^UTILITY(U,$J,358.3,20134,2)
 ;;=^5003239
 ;;^UTILITY(U,$J,358.3,20135,0)
 ;;=F14.20^^67^858^32
 ;;^UTILITY(U,$J,358.3,20135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20135,1,3,0)
 ;;=3^Cocaine Use DO,Mod/Sev,Uncomp
 ;;^UTILITY(U,$J,358.3,20135,1,4,0)
 ;;=4^F14.20
 ;;^UTILITY(U,$J,358.3,20135,2)
 ;;=^5003253
 ;;^UTILITY(U,$J,358.3,20136,0)
 ;;=F14.23^^67^858^33
 ;;^UTILITY(U,$J,358.3,20136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20136,1,3,0)
 ;;=3^Cocaine Withdrawal
 ;;^UTILITY(U,$J,358.3,20136,1,4,0)
 ;;=4^F14.23
 ;;^UTILITY(U,$J,358.3,20136,2)
 ;;=^5003259
 ;;^UTILITY(U,$J,358.3,20137,0)
 ;;=F14.21^^67^858^31
 ;;^UTILITY(U,$J,358.3,20137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20137,1,3,0)
 ;;=3^Cocaine Use DO,Mod/Sev,In Remiss
 ;;^UTILITY(U,$J,358.3,20137,1,4,0)
 ;;=4^F14.21
 ;;^UTILITY(U,$J,358.3,20137,2)
 ;;=^5003254
 ;;^UTILITY(U,$J,358.3,20138,0)
 ;;=F15.11^^67^858^63
 ;;^UTILITY(U,$J,358.3,20138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20138,1,3,0)
 ;;=3^Oth Stimulant Mild Use D/O,In Remission
 ;;^UTILITY(U,$J,358.3,20138,1,4,0)
 ;;=4^F15.11
 ;;^UTILITY(U,$J,358.3,20138,2)
 ;;=^5151304
 ;;^UTILITY(U,$J,358.3,20139,0)
 ;;=F14.11^^67^858^29
 ;;^UTILITY(U,$J,358.3,20139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20139,1,3,0)
 ;;=3^Cocaine Use DO,Mild,In Remiss
 ;;^UTILITY(U,$J,358.3,20139,1,4,0)
 ;;=4^F14.11
 ;;^UTILITY(U,$J,358.3,20139,2)
 ;;=^268249
 ;;^UTILITY(U,$J,358.3,20140,0)
 ;;=F15.21^^67^858^34
 ;;^UTILITY(U,$J,358.3,20140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20140,1,3,0)
 ;;=3^Oth Stimulant Dependence,Mod/Sev,In Remission
 ;;^UTILITY(U,$J,358.3,20140,1,4,0)
 ;;=4^F15.21
 ;;^UTILITY(U,$J,358.3,20140,2)
 ;;=^5003296
 ;;^UTILITY(U,$J,358.3,20141,0)
 ;;=Z91.120^^67^859^1
 ;;^UTILITY(U,$J,358.3,20141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20141,1,3,0)
 ;;=3^Intentional Underdosing d/t Financial Hardship
 ;;^UTILITY(U,$J,358.3,20141,1,4,0)
 ;;=4^Z91.120
 ;;^UTILITY(U,$J,358.3,20141,2)
 ;;=^5063612
 ;;^UTILITY(U,$J,358.3,20142,0)
 ;;=Z91.128^^67^859^2
 ;;^UTILITY(U,$J,358.3,20142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20142,1,3,0)
 ;;=3^Intentional Underdosing,Other Reasons
 ;;^UTILITY(U,$J,358.3,20142,1,4,0)
 ;;=4^Z91.128
 ;;^UTILITY(U,$J,358.3,20142,2)
 ;;=^5063613
 ;;^UTILITY(U,$J,358.3,20143,0)
 ;;=Z91.130^^67^859^15
 ;;^UTILITY(U,$J,358.3,20143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20143,1,3,0)
 ;;=3^Unintented Underdosing d/t Age-Related Disability
 ;;^UTILITY(U,$J,358.3,20143,1,4,0)
 ;;=4^Z91.130
 ;;^UTILITY(U,$J,358.3,20143,2)
 ;;=^5063614
 ;;^UTILITY(U,$J,358.3,20144,0)
 ;;=Z91.138^^67^859^16
 ;;^UTILITY(U,$J,358.3,20144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20144,1,3,0)
 ;;=3^Unintented Underdosing,Other Reasons
 ;;^UTILITY(U,$J,358.3,20144,1,4,0)
 ;;=4^Z91.138
 ;;^UTILITY(U,$J,358.3,20144,2)
 ;;=^5063615
 ;;^UTILITY(U,$J,358.3,20145,0)
 ;;=T38.3X6A^^67^859^3
 ;;^UTILITY(U,$J,358.3,20145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20145,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Init Encntr
 ;;^UTILITY(U,$J,358.3,20145,1,4,0)
 ;;=4^T38.3X6A
 ;;^UTILITY(U,$J,358.3,20145,2)
 ;;=^5049649
 ;;^UTILITY(U,$J,358.3,20146,0)
 ;;=T38.3X6S^^67^859^4
 ;;^UTILITY(U,$J,358.3,20146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20146,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
 ;;^UTILITY(U,$J,358.3,20146,1,4,0)
 ;;=4^T38.3X6S
 ;;^UTILITY(U,$J,358.3,20146,2)
 ;;=^5049651
 ;;^UTILITY(U,$J,358.3,20147,0)
 ;;=T38.3X6D^^67^859^5
 ;;^UTILITY(U,$J,358.3,20147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20147,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
 ;;^UTILITY(U,$J,358.3,20147,1,4,0)
 ;;=4^T38.3X6D
 ;;^UTILITY(U,$J,358.3,20147,2)
 ;;=^5049650
 ;;^UTILITY(U,$J,358.3,20148,0)
 ;;=T46.5X6A^^67^859^9
 ;;^UTILITY(U,$J,358.3,20148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20148,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
 ;;^UTILITY(U,$J,358.3,20148,1,4,0)
 ;;=4^T46.5X6A
 ;;^UTILITY(U,$J,358.3,20148,2)
 ;;=^5051353
 ;;^UTILITY(U,$J,358.3,20149,0)
 ;;=T46.5X6D^^67^859^10
 ;;^UTILITY(U,$J,358.3,20149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20149,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
 ;;^UTILITY(U,$J,358.3,20149,1,4,0)
 ;;=4^T46.5X6D
 ;;^UTILITY(U,$J,358.3,20149,2)
 ;;=^5051354
 ;;^UTILITY(U,$J,358.3,20150,0)
 ;;=T46.5X6S^^67^859^11
 ;;^UTILITY(U,$J,358.3,20150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20150,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Sequela
 ;;^UTILITY(U,$J,358.3,20150,1,4,0)
 ;;=4^T46.5X6S
 ;;^UTILITY(U,$J,358.3,20150,2)
 ;;=^5051355
 ;;^UTILITY(U,$J,358.3,20151,0)
 ;;=T43.206A^^67^859^6
 ;;^UTILITY(U,$J,358.3,20151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20151,1,3,0)
 ;;=3^Underdosing of Antidepressants,Init Encntr
 ;;^UTILITY(U,$J,358.3,20151,1,4,0)
 ;;=4^T43.206A
 ;;^UTILITY(U,$J,358.3,20151,2)
 ;;=^5050543
 ;;^UTILITY(U,$J,358.3,20152,0)
 ;;=T43.206S^^67^859^7
 ;;^UTILITY(U,$J,358.3,20152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20152,1,3,0)
 ;;=3^Underdosing of Antidepressants,Sequela
 ;;^UTILITY(U,$J,358.3,20152,1,4,0)
 ;;=4^T43.206S
 ;;^UTILITY(U,$J,358.3,20152,2)
 ;;=^5050545
 ;;^UTILITY(U,$J,358.3,20153,0)
 ;;=T43.206D^^67^859^8
 ;;^UTILITY(U,$J,358.3,20153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20153,1,3,0)
 ;;=3^Underdosing of Antidepressants,Subs Encntr
 ;;^UTILITY(U,$J,358.3,20153,1,4,0)
 ;;=4^T43.206D
 ;;^UTILITY(U,$J,358.3,20153,2)
 ;;=^5050544
 ;;^UTILITY(U,$J,358.3,20154,0)
 ;;=T43.506A^^67^859^12
 ;;^UTILITY(U,$J,358.3,20154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20154,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
 ;;^UTILITY(U,$J,358.3,20154,1,4,0)
 ;;=4^T43.506A
 ;;^UTILITY(U,$J,358.3,20154,2)
 ;;=^5050651
 ;;^UTILITY(U,$J,358.3,20155,0)
 ;;=T43.506S^^67^859^13
 ;;^UTILITY(U,$J,358.3,20155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20155,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Sequela
 ;;^UTILITY(U,$J,358.3,20155,1,4,0)
 ;;=4^T43.506S
 ;;^UTILITY(U,$J,358.3,20155,2)
 ;;=^5050653
 ;;^UTILITY(U,$J,358.3,20156,0)
 ;;=T43.506D^^67^859^14
 ;;^UTILITY(U,$J,358.3,20156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20156,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Subs Encntr
 ;;^UTILITY(U,$J,358.3,20156,1,4,0)
 ;;=4^T43.506D
 ;;^UTILITY(U,$J,358.3,20156,2)
 ;;=^5050652
 ;;^UTILITY(U,$J,358.3,20157,0)
 ;;=99211^^68^860^1
 ;;^UTILITY(U,$J,358.3,20157,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,20157,1,1,0)
 ;;=1^NURSING VISIT
 ;;^UTILITY(U,$J,358.3,20157,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,20158,0)
 ;;=J3420^^69^861^12^^^^1
 ;;^UTILITY(U,$J,358.3,20158,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20158,1,2,0)
 ;;=2^J3420
 ;;^UTILITY(U,$J,358.3,20158,1,3,0)
 ;;=3^B12 INJ. UP TO 1,000MCG
 ;;^UTILITY(U,$J,358.3,20159,0)
 ;;=J0800^^69^861^23^^^^1
 ;;^UTILITY(U,$J,358.3,20159,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20159,1,2,0)
 ;;=2^J0800
 ;;^UTILITY(U,$J,358.3,20159,1,3,0)
 ;;=3^CORTISON INJ, UP TO 40U
 ;;^UTILITY(U,$J,358.3,20160,0)
 ;;=J1631^^69^861^42^^^^1
 ;;^UTILITY(U,$J,358.3,20160,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20160,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,20160,1,3,0)
 ;;=3^HALDOL 50MG
 ;;^UTILITY(U,$J,358.3,20161,0)
 ;;=J2680^^69^861^86^^^^1
 ;;^UTILITY(U,$J,358.3,20161,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20161,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,20161,1,3,0)
 ;;=3^PROLIXIN INJ UP TO 25MG
 ;;^UTILITY(U,$J,358.3,20162,0)
 ;;=J1630^^69^861^43^^^^1
 ;;^UTILITY(U,$J,358.3,20162,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20162,1,2,0)
 ;;=2^J1630
 ;;^UTILITY(U,$J,358.3,20162,1,3,0)
 ;;=3^HALDOL 5MG
 ;;^UTILITY(U,$J,358.3,20163,0)
 ;;=J9202^^69^861^104^^^^1
 ;;^UTILITY(U,$J,358.3,20163,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20163,1,2,0)
 ;;=2^J9202
 ;;^UTILITY(U,$J,358.3,20163,1,3,0)
 ;;=3^ZOLADEX 3.6MG
 ;;^UTILITY(U,$J,358.3,20164,0)
 ;;=J0885^^69^861^28^^^^1
 ;;^UTILITY(U,$J,358.3,20164,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20164,1,2,0)
 ;;=2^J0885
 ;;^UTILITY(U,$J,358.3,20164,1,3,0)
 ;;=3^EPOGEN INJ, NON-ESRD 1000 UNITS
 ;;^UTILITY(U,$J,358.3,20165,0)
 ;;=J0881^^69^861^11^^^^1
 ;;^UTILITY(U,$J,358.3,20165,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20165,1,2,0)
 ;;=2^J0881
 ;;^UTILITY(U,$J,358.3,20165,1,3,0)
 ;;=3^ARANESP (NON-ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,20166,0)
 ;;=J0882^^69^861^10^^^^1
 ;;^UTILITY(U,$J,358.3,20166,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20166,1,2,0)
 ;;=2^J0882
 ;;^UTILITY(U,$J,358.3,20166,1,3,0)
 ;;=3^ARANESP (ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,20167,0)
 ;;=J1826^^69^861^49^^^^1
 ;;^UTILITY(U,$J,358.3,20167,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20167,1,2,0)
 ;;=2^J1826
 ;;^UTILITY(U,$J,358.3,20167,1,3,0)
 ;;=3^INTERFERON BETA-1A 30mcg
 ;;^UTILITY(U,$J,358.3,20168,0)
 ;;=J9217^^69^861^59^^^^1
 ;;^UTILITY(U,$J,358.3,20168,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20168,1,2,0)
 ;;=2^J9217
 ;;^UTILITY(U,$J,358.3,20168,1,3,0)
 ;;=3^LEUPROLIDE INJ 7.5MG
 ;;^UTILITY(U,$J,358.3,20169,0)
 ;;=J9218^^69^861^57^^^^1
 ;;^UTILITY(U,$J,358.3,20169,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20169,1,2,0)
 ;;=2^J9218
 ;;^UTILITY(U,$J,358.3,20169,1,3,0)
 ;;=3^LEUPROLIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,20170,0)
 ;;=J1950^^69^861^58^^^^1
 ;;^UTILITY(U,$J,358.3,20170,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20170,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,20170,1,3,0)
 ;;=3^LEUPROLIDE INJ 3.75MG
 ;;^UTILITY(U,$J,358.3,20171,0)
 ;;=J9219^^69^861^56^^^^1
 ;;^UTILITY(U,$J,358.3,20171,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20171,1,2,0)
 ;;=2^J9219
 ;;^UTILITY(U,$J,358.3,20171,1,3,0)
 ;;=3^LEUPROLIDE IMPLANT 65MG
 ;;^UTILITY(U,$J,358.3,20172,0)
 ;;=J0696^^69^861^93^^^^1
 ;;^UTILITY(U,$J,358.3,20172,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20172,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,20172,1,3,0)
 ;;=3^ROCEPHIN INJ-250MG
 ;;^UTILITY(U,$J,358.3,20173,0)
 ;;=J0696^^69^861^92^^^^4
 ;;^UTILITY(U,$J,358.3,20173,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20173,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,20173,1,3,0)
 ;;=3^ROCEPHIN INJ-1GM
 ;;^UTILITY(U,$J,358.3,20174,0)
 ;;=J1030^^69^861^64^^^^1
 ;;^UTILITY(U,$J,358.3,20174,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20174,1,2,0)
 ;;=2^J1030
 ;;^UTILITY(U,$J,358.3,20174,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 40MG
 ;;^UTILITY(U,$J,358.3,20175,0)
 ;;=J1020^^69^861^63^^^^1
 ;;^UTILITY(U,$J,358.3,20175,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20175,1,2,0)
 ;;=2^J1020
 ;;^UTILITY(U,$J,358.3,20175,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 20MG
 ;;^UTILITY(U,$J,358.3,20176,0)
 ;;=J1040^^69^861^65^^^^1
 ;;^UTILITY(U,$J,358.3,20176,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20176,1,2,0)
 ;;=2^J1040
 ;;^UTILITY(U,$J,358.3,20176,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 80MG
 ;;^UTILITY(U,$J,358.3,20177,0)
 ;;=J2920^^69^861^67^^^^1
 ;;^UTILITY(U,$J,358.3,20177,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20177,1,2,0)
 ;;=2^J2920
 ;;^UTILITY(U,$J,358.3,20177,1,3,0)
 ;;=3^METHYLPREDNISOLONE SOD IV 40MG
 ;;^UTILITY(U,$J,358.3,20178,0)
 ;;=J2930^^69^861^66^^^^1
 ;;^UTILITY(U,$J,358.3,20178,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20178,1,2,0)
 ;;=2^J2930
 ;;^UTILITY(U,$J,358.3,20178,1,3,0)
 ;;=3^METHYLPREDNISOLONE SOD IV 125MG
 ;;^UTILITY(U,$J,358.3,20179,0)
 ;;=J1756^^69^861^51^^^^1
 ;;^UTILITY(U,$J,358.3,20179,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20179,1,2,0)
 ;;=2^J1756
 ;;^UTILITY(U,$J,358.3,20179,1,3,0)
 ;;=3^IRON SUCROSE INJ 1MG
 ;;^UTILITY(U,$J,358.3,20180,0)
 ;;=J1745^^69^861^90^^^^1
 ;;^UTILITY(U,$J,358.3,20180,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20180,1,2,0)
 ;;=2^J1745
 ;;^UTILITY(U,$J,358.3,20180,1,3,0)
 ;;=3^REMICADE 10MG
 ;;^UTILITY(U,$J,358.3,20181,0)
 ;;=J2916^^69^861^32^^^^1
 ;;^UTILITY(U,$J,358.3,20181,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20181,1,2,0)
 ;;=2^J2916
 ;;^UTILITY(U,$J,358.3,20181,1,3,0)
 ;;=3^FERRIC GLUCOMATE 12.5MG
 ;;^UTILITY(U,$J,358.3,20182,0)
 ;;=J0129^^69^861^2^^^^1
 ;;^UTILITY(U,$J,358.3,20182,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20182,1,2,0)
 ;;=2^J0129
 ;;^UTILITY(U,$J,358.3,20182,1,3,0)
 ;;=3^ABATACEPT INJ 10MG
 ;;^UTILITY(U,$J,358.3,20183,0)
 ;;=J1460^^69^861^37^^^^1
 ;;^UTILITY(U,$J,358.3,20183,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20183,1,2,0)
 ;;=2^J1460
 ;;^UTILITY(U,$J,358.3,20183,1,3,0)
 ;;=3^GAMMA GLOBULIN INJ 1CC
 ;;^UTILITY(U,$J,358.3,20184,0)
 ;;=J1560^^69^861^38^^^^1
 ;;^UTILITY(U,$J,358.3,20184,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20184,1,2,0)
 ;;=2^J1560
 ;;^UTILITY(U,$J,358.3,20184,1,3,0)
 ;;=3^GAMMA GLOBULIN INJ > 10CC
 ;;^UTILITY(U,$J,358.3,20185,0)
 ;;=J1561^^69^861^40^^^^1
 ;;^UTILITY(U,$J,358.3,20185,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20185,1,2,0)
 ;;=2^J1561
 ;;^UTILITY(U,$J,358.3,20185,1,3,0)
 ;;=3^GAMUNEX 500MG
 ;;^UTILITY(U,$J,358.3,20186,0)
 ;;=J2353^^69^861^75^^^^1
 ;;^UTILITY(U,$J,358.3,20186,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20186,1,2,0)
 ;;=2^J2353
 ;;^UTILITY(U,$J,358.3,20186,1,3,0)
 ;;=3^OCTREOTIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,20187,0)
 ;;=J1930^^69^861^55^^^^1
 ;;^UTILITY(U,$J,358.3,20187,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20187,1,2,0)
 ;;=2^J1930
 ;;^UTILITY(U,$J,358.3,20187,1,3,0)
 ;;=3^LANREOTIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,20188,0)
 ;;=J0561^^69^861^81^^^^1
 ;;^UTILITY(U,$J,358.3,20188,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20188,1,2,0)
 ;;=2^J0561
 ;;^UTILITY(U,$J,358.3,20188,1,3,0)
 ;;=3^PEN G BENZATHINE 100,000 UNITS
 ;;^UTILITY(U,$J,358.3,20189,0)
 ;;=J0558^^69^861^82^^^^1
 ;;^UTILITY(U,$J,358.3,20189,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20189,1,2,0)
 ;;=2^J0558
 ;;^UTILITY(U,$J,358.3,20189,1,3,0)
 ;;=3^PEN G BENZATHINE/PROCAINE INJ 100,000 UNITS
 ;;^UTILITY(U,$J,358.3,20190,0)
 ;;=J2540^^69^861^83^^^^1
 ;;^UTILITY(U,$J,358.3,20190,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20190,1,2,0)
 ;;=2^J2540
 ;;^UTILITY(U,$J,358.3,20190,1,3,0)
 ;;=3^PEN G POTASSIUM INJ 600,000 UNITS
 ;;^UTILITY(U,$J,358.3,20191,0)
 ;;=J2510^^69^861^84^^^^1
 ;;^UTILITY(U,$J,358.3,20191,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20191,1,2,0)
 ;;=2^J2510
 ;;^UTILITY(U,$J,358.3,20191,1,3,0)
 ;;=3^PEN G PROCAINE INJ UP TO 600,000 UNITS
 ;;^UTILITY(U,$J,358.3,20192,0)
 ;;=J3370^^69^861^101^^^^1
 ;;^UTILITY(U,$J,358.3,20192,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20192,1,2,0)
 ;;=2^J3370
 ;;^UTILITY(U,$J,358.3,20192,1,3,0)
 ;;=3^VANCOMYCIN HCI INJ 500MG
 ;;^UTILITY(U,$J,358.3,20193,0)
 ;;=J0696^^69^861^21^^^^1
 ;;^UTILITY(U,$J,358.3,20193,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20193,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,20193,1,3,0)
 ;;=3^CEFTRIAXONE SODIUM INJ 250MG
 ;;^UTILITY(U,$J,358.3,20194,0)
 ;;=J0692^^69^861^18^^^^1
 ;;^UTILITY(U,$J,358.3,20194,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20194,1,2,0)
 ;;=2^J0692
 ;;^UTILITY(U,$J,358.3,20194,1,3,0)
 ;;=3^CEFEPIME HCL INJ 500MG
 ;;^UTILITY(U,$J,358.3,20195,0)
 ;;=J2185^^69^861^62^^^^1
 ;;^UTILITY(U,$J,358.3,20195,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20195,1,2,0)
 ;;=2^J2185
 ;;^UTILITY(U,$J,358.3,20195,1,3,0)
 ;;=3^MEROPENEM 100MG
 ;;^UTILITY(U,$J,358.3,20196,0)
 ;;=J1200^^69^861^27^^^^1
 ;;^UTILITY(U,$J,358.3,20196,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20196,1,2,0)
 ;;=2^J1200
 ;;^UTILITY(U,$J,358.3,20196,1,3,0)
 ;;=3^DIPHENHYDRAMINE HCL INJ 50MG
 ;;^UTILITY(U,$J,358.3,20197,0)
 ;;=J2780^^69^861^88^^^^1
 ;;^UTILITY(U,$J,358.3,20197,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20197,1,2,0)
 ;;=2^J2780
 ;;^UTILITY(U,$J,358.3,20197,1,3,0)
 ;;=3^RANITIDINE HCL INJ 25MG
 ;;^UTILITY(U,$J,358.3,20198,0)
 ;;=J2997^^69^861^9^^^^1
 ;;^UTILITY(U,$J,358.3,20198,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20198,1,2,0)
 ;;=2^J2997
 ;;^UTILITY(U,$J,358.3,20198,1,3,0)
 ;;=3^ALTEPLASE RECOMBINANT 1MG
 ;;^UTILITY(U,$J,358.3,20199,0)
 ;;=J1094^^69^861^25^^^^1
 ;;^UTILITY(U,$J,358.3,20199,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20199,1,2,0)
 ;;=2^J1094
 ;;^UTILITY(U,$J,358.3,20199,1,3,0)
 ;;=3^DEXAMETHASONE ACETATE 1MG
 ;;^UTILITY(U,$J,358.3,20200,0)
 ;;=J1100^^69^861^26^^^^1
 ;;^UTILITY(U,$J,358.3,20200,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20200,1,2,0)
 ;;=2^J1100
 ;;^UTILITY(U,$J,358.3,20200,1,3,0)
 ;;=3^DEXAMETHASONE SODIUM PHOS 1MG
 ;;^UTILITY(U,$J,358.3,20201,0)
 ;;=J9395^^69^861^36^^^^1
 ;;^UTILITY(U,$J,358.3,20201,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20201,1,2,0)
 ;;=2^J9395
 ;;^UTILITY(U,$J,358.3,20201,1,3,0)
 ;;=3^FULVESTRANT INJ 25MG
 ;;^UTILITY(U,$J,358.3,20202,0)
 ;;=96402^^69^861^105^^^^1
 ;;^UTILITY(U,$J,358.3,20202,1,0)
 ;;=^358.31IA^3^2
